NPSP ($5.10)..An analyst with Canaccord mentioned there were 2 deaths in the trial even though they cannot pinpoint that it was due to Gattex. I don't know enough about the drug or the company to provide further detail. Has not been a stock on my radar.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.